BNR - Burning Rock Biotech GAAP EPS of -$0.23 revenue of $17.5M November, 30 2023 02:30 AM Burning Rock Biotech Limited 2023-11-30 02:30:48 ET More on Burning Rock Biotech Burning Rock's cancer detection blood test OverC gets breakthrough device status in China Seeking Alpha’s Quant Rating on Burning Rock Biotech For further details see: Burning Rock Biotech GAAP EPS of -$0.23, revenue of $17.5M